Korea adds Pergoveris pen to reimbursement rolls, vial already covered
This is a device listing, not an eligibility expansion. The indication is unchanged, and the criteria were relaxed back in April 2025.
Merck Group
This is a device listing, not an eligibility expansion. The indication is unchanged, and the criteria were relaxed back in April 2025.